Sanofi India Ltd - 500674 - Sanofi India Limited Has Informed The Exchange Regarding An Exclusive Distribution And Promotion Agreement For Cardiovascular Products Between Sanofi India Limited And Emcure Pharmaceuticals Limited
Please find enclosed a Press Release for further details. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the Notice to Shareholders of the Company regarding transfer of shares to IEPF, published on 8th March, 2024. Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s). Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share certificates requests in lieu of the original share certificates reported lost/misplaced. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find enclosed herewith transcript of the Investors / Analysts Call scheduled on 26th February 2024. The same is also being uploaded on the website of the Company. Sanofi India Ltd - 500674 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, Secretarial Compliance Report for the year ended 31st December, 2023. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Please find enclosed herewith the presentation made to the Investors / Analysts Call and the same is also being uploaded on the website of the Company. The recording and transcript of the Call thereof will be submitted to Stock Exchanges in due course and simultaneously be uploaded on the website of the Company. Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of Newspaper publication of financial results for quarter and year ended 31st December 2023, of the Company published on 24th February 2024, in Business Standard and Sakal newspapers.
Sanofi India Results Earnings Call for Q4CY23
Conference Call with Sanofi India Management and Analysts on Q4CY23 Performance and Outlook. Listen to the full earnings transcript.